Stock Quality:
Last 7 days
-2.4%
Last 30 days
9.8%
Last 90 days
-24.5%
Trailing 12 Months
-69.2%
NTLA RSI Chart
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Revenue Breakdown
|
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2025 | 45.6M | 0 | 0 | 0 |
2024 | 41.7M | 47.1M | 52.5M | 57.9M |
2023 | 53.5M | 53.0M | 51.8M | 36.3M |
2022 | 37.9M | 45.3M | 51.4M | 52.1M |
2021 | 51.5M | 41.8M | 26.8M | 33.1M |
2020 | 45.6M | 50.7M | 62.3M | 58.0M |
2019 | 33.4M | 36.8M | 40.0M | 43.1M |
2018 | 27.4M | 29.1M | 29.2M | 30.4M |
2017 | 20.9M | 22.6M | 25.1M | 26.1M |
2016 | 6.5M | 9.4M | 12.5M | 16.5M |
2015 | 0 | 0 | 0 | 6.0M |
CEO | Dr. John M. Leonard M.D. |
---|---|
WEBSITE | intelliatx.com |
SECTOR | Healthcare |
INDUSTRY | Biotechnology |
EMPLOYEES | 598 |